Process View
The network for 'b cell proliferation' in your query organism is displayed on the left, if relationships are supported by the integrated data. Moving any of the genes in that network will simultaneously update the homologs in the networks displayed to the right (if they exist). Additionally, hovering over any nodes will highlight the identified functionally similar homologs in the other networks. Last, the bar above the networks allows you to remove/add additional organisms. Simily drag and drop the organism names in the desired order.
The expansion of a B cell population by cell division. Follows B cell activation.
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
Igh | immunoglobulin heavy chain complex | 1.000 | |
Rnf2 | ring finger protein 2 | 0.998 | |
Cd40 | CD40 antigen | 0.995 | |
Cd19 | CD19 antigen | 0.995 | |
Tlr4 | toll-like receptor 4 | 0.993 | |
Lyn | Yamaguchi sarcoma viral (v-yes-1) oncogene homolog | 0.992 | |
Btk | Bruton agammaglobulinemia tyrosine kinase | 0.988 | |
Ikzf1 | IKAROS family zinc finger 1 | 0.984 | |
Tnf | tumor necrosis factor | 0.969 | |
Bcl2 | B-cell leukemia/lymphoma 2 | 0.961 | |
Cd22 | CD22 antigen | 0.955 | |
Ikzf3 | IKAROS family zinc finger 3 | 0.941 | |
Rybp | RING1 and YY1 binding protein | 0.939 | |
Fyn | Fyn proto-oncogene | 0.939 | |
Bcl2l11 | BCL2-like 11 (apoptosis facilitator) | 0.923 | |
Cd28 | CD28 antigen | 0.909 | |
Pik3cd | phosphatidylinositol 3-kinase catalytic delta polypeptide | 0.907 | |
Ifng | interferon gamma | 0.896 | |
Pou2af1 | POU domain, class 2, associating factor 1 | 0.891 | |
Inpp5d | inositol polyphosphate-5-phosphatase D | 0.888 | |
Il4 | interleukin 4 | 0.821 | |
Pik3r1 | phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) | 0.814 | |
Cdkn1b | cyclin-dependent kinase inhibitor 1B | 0.813 | |
Casp1 | caspase 1 | 0.726 | |
Lyz2 | lysozyme 2 | 0.717 | |
Casp4 | caspase 4, apoptosis-related cysteine peptidase | 0.716 | |
Chrnb2 | cholinergic receptor, nicotinic, beta polypeptide 2 (neuronal) | 0.692 | |
Hdac7 | histone deacetylase 7 | 0.672 | |
Dok1 | docking protein 1 | 0.620 | |
Chrnb4 | cholinergic receptor, nicotinic, beta polypeptide 4 | 0.615 | |
Ptk2 | PTK2 protein tyrosine kinase 2 | 0.612 | |
Cd4 | CD4 antigen | 0.598 | |
Myd88 | myeloid differentiation primary response gene 88 | 0.595 | |
Prkcd | protein kinase C, delta | 0.551 | |
Plcg2 | phospholipase C, gamma 2 | 0.536 | |
Esr1 | estrogen receptor 1 (alpha) | 0.531 | |
Ccr2 | chemokine (C-C motif) receptor 2 | 0.527 | |
Cd72 | CD72 antigen | 0.526 | |
Icos | inducible T-cell co-stimulator | 0.524 | |
Spib | Spi-B transcription factor (Spi-1/PU.1 related) | 0.524 | |
Il2 | interleukin 2 | 0.504 | |
Blnk | B-cell linker | 0.503 | |
Cd79b | CD79B antigen | 0.477 | |
Tgfb1 | transforming growth factor, beta 1 | 0.467 | |
Fcer1g | Fc receptor, IgE, high affinity I, gamma polypeptide | 0.461 | |
Ptprc | protein tyrosine phosphatase, receptor type, C | 0.459 | |
Card11 | caspase recruitment domain family, member 11 | 0.456 | |
Prf1 | perforin 1 (pore forming protein) | 0.446 | |
Bcl6 | B-cell leukemia/lymphoma 6 | 0.443 | |
Tnfrsf13b | tumor necrosis factor receptor superfamily, member 13b | 0.441 | |
Slc6a3 | solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 | 0.416 | |
Lama5 | laminin, alpha 5 | 0.416 | |
Tnfrsf13c | tumor necrosis factor receptor superfamily, member 13c | 0.413 | |
Sykb | spleen tyrosine kinase | 0.410 | |
Cr2 | complement receptor 2 | 0.409 | |
Cd40lg | CD40 ligand | 0.407 | |
Ptpn22 | protein tyrosine phosphatase, non-receptor type 22 (lymphoid) | 0.394 | |
Fas | Fas (TNF receptor superfamily member 6) | 0.390 | |
Cd247 | CD247 antigen | 0.388 | |
Socs1 | suppressor of cytokine signaling 1 | 0.386 | |
Fasl | Fas ligand (TNF superfamily, member 6) | 0.384 | |
Cbl | Casitas B-lineage lymphoma | 0.374 | |
Trp63 | transformation related protein 63 | 0.373 | |
Hif1a | hypoxia inducible factor 1, alpha subunit | 0.365 | |
Rc3h1 | RING CCCH (C3H) domains 1 | 0.328 | |
Tnfaip3 | tumor necrosis factor, alpha-induced protein 3 | 0.320 | |
Ptpn6 | protein tyrosine phosphatase, non-receptor type 6 | 0.320 | |
Lta | lymphotoxin A | 0.310 | |
Il10 | interleukin 10 | 0.309 | |
Chrna3 | cholinergic receptor, nicotinic, alpha polypeptide 3 | 0.308 | |
Trp53 | transformation related protein 53 | 0.306 | |
Grb2 | growth factor receptor bound protein 2 | 0.290 | |
Ccr3 | chemokine (C-C motif) receptor 3 | 0.283 | |
Clec4n | C-type lectin domain family 4, member n | 0.283 | |
Igk | immunoglobulin kappa chain complex | 0.283 | |
Il2rb | interleukin 2 receptor, beta chain | 0.283 | |
Nos2 | nitric oxide synthase 2, inducible | 0.282 | |
Insr | insulin receptor | 0.280 | |
Tbxa2r | thromboxane A2 receptor | 0.270 | |
Map3k7 | mitogen-activated protein kinase kinase kinase 7 | 0.269 | |
Cd14 | CD14 antigen | 0.265 | |
Abcg3 | ATP-binding cassette, sub-family G (WHITE), member 3 | 0.261 | |
Il6 | interleukin 6 | 0.252 | |
Blk | B lymphoid kinase | 0.251 | |
Bak1 | BCL2-antagonist/killer 1 | 0.246 | |
Pten | phosphatase and tensin homolog | 0.245 | |
Ptgs2 | prostaglandin-endoperoxide synthase 2 | 0.243 | |
Aire | autoimmune regulator (autoimmune polyendocrinopathy candidiasis ectodermal dystrophy) | 0.240 | |
Mdm2 | transformed mouse 3T3 cell double minute 2 | 0.238 | |
Hdac4 | histone deacetylase 4 | 0.229 | |
Foxn1 | forkhead box N1 | 0.227 | |
Lck | lymphocyte protein tyrosine kinase | 0.223 | |
Nfkb1 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1, p105 | 0.218 | |
Tlr2 | toll-like receptor 2 | 0.213 | |
Rag1 | recombination activating gene 1 | 0.210 | |
Brca1 | breast cancer 1 | 0.208 | |
Spp1 | secreted phosphoprotein 1 | 0.199 | |
Dok2 | docking protein 2 | 0.196 | |
Ccr6 | chemokine (C-C motif) receptor 6 | 0.196 | |
H2-Aa | histocompatibility 2, class II antigen A, alpha | 0.195 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
tlr21 | toll-like receptor 21 | 0.019 | |
si:dkey-91i17.1 | si:dkey-91i17.1 | 0.018 | |
coro1a | coronin, actin binding protein, 1A | 0.018 | |
sox3 | SRY-box containing gene 3 | 0.018 | |
rerea | arginine-glutamic acid dipeptide (RE) repeats a | 0.017 | |
plcb3 | phospholipase C, beta 3 (phosphatidylinositol-specific) | 0.017 | |
bmi1b | B lymphoma Mo-MLV insertion region 1b | 0.014 | |
ezr | ezrin | 0.014 | |
lars | leucyl-tRNA synthetase | 0.014 | |
arntl1b | aryl hydrocarbon receptor nuclear translocator-like 1b | 0.014 | |
wnt3 | wingless-type MMTV integration site family, member 3 | 0.013 | |
csrnp1b | cysteine-serine-rich nuclear protein 1b | 0.013 | |
insrb | insulin receptor b | 0.013 | |
ckbb | creatine kinase, brain b | 0.012 | |
asb8 | ankyrin repeat and SOCS box-containing 8 | 0.012 | |
sb:cb472 | sb:cb472 | 0.012 | |
zgc:66317 | zgc:66317 | 0.012 | |
ptp4a3 | protein tyrosine phosphatase type IVA, member 3 | 0.012 | |
rag1 | recombination activating gene 1 | 0.012 | |
bcl2l10 | BCL2-like 10 (apoptosis facilitator) | 0.011 | |
hspa9 | heat shock protein 9 | 0.011 | |
traf4a | tnf receptor-associated factor 4a | 0.011 | |
disc1 | disrupted in schizophrenia 1 | 0.011 | |
zgc:101606 | zgc:101606 | 0.011 | |
zgc:56039 | zgc:56039 | 0.010 | |
mep1a.1 | meprin A, alpha.1 | 0.010 | |
tp53 | tumor protein p53 | 0.010 | |
eif2ak3 | eukaryotic translation initiation factor 2-alpha kinase 3 | 0.010 | |
fras1 | Fraser syndrome 1 | 0.010 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.862 | |
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.834 | |
IL4R | interleukin 4 receptor | 0.666 | |
CBL | Cas-Br-M (murine) ecotropic retroviral transforming sequence | 0.423 | |
SHC1 | SHC (Src homology 2 domain containing) transforming protein 1 | 0.404 | |
SYK | spleen tyrosine kinase | 0.361 | |
ERBB2 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) | 0.356 | |
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.332 | |
IL10RA | interleukin 10 receptor, alpha | 0.234 | |
ABL1 | c-abl oncogene 1, non-receptor tyrosine kinase | 0.222 | |
CD80 | CD80 molecule | 0.221 | |
LCP2 | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 0.179 | |
MS4A1 | membrane-spanning 4-domains, subfamily A, member 1 | 0.154 | |
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.131 | |
TAL1 | T-cell acute lymphocytic leukemia 1 | 0.123 | |
CASP9 | caspase 9, apoptosis-related cysteine peptidase | 0.106 | |
INPP5D | inositol polyphosphate-5-phosphatase, 145kDa | 0.098 | |
CD22 | CD22 molecule | 0.096 | |
CD79B | CD79b molecule, immunoglobulin-associated beta | 0.095 | |
BCL2 | B-cell CLL/lymphoma 2 | 0.094 | |
TICAM2 | toll-like receptor adaptor molecule 2 | 0.092 | |
LAT | linker for activation of T cells | 0.089 | |
BCL2L1 | BCL2-like 1 | 0.082 | |
IL2RG | interleukin 2 receptor, gamma | 0.080 | |
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.080 | |
MYD88 | myeloid differentiation primary response gene (88) | 0.080 | |
SLAMF1 | signaling lymphocytic activation molecule family member 1 | 0.077 | |
APAF1 | apoptotic peptidase activating factor 1 | 0.069 | |
BLNK | B-cell linker | 0.069 | |
SH3BP2 | SH3-domain binding protein 2 | 0.066 | |
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.063 | |
IL22RA2 | interleukin 22 receptor, alpha 2 | 0.062 | |
EP300 | E1A binding protein p300 | 0.054 | |
XIAP | X-linked inhibitor of apoptosis | 0.054 | |
HLA-DPA1 | major histocompatibility complex, class II, DP alpha 1 | 0.051 | |
CCR7 | chemokine (C-C motif) receptor 7 | 0.049 | |
CD86 | CD86 molecule | 0.047 | |
GRAP2 | GRB2-related adaptor protein 2 | 0.046 | |
CDK6 | cyclin-dependent kinase 6 | 0.045 | |
CDK2 | cyclin-dependent kinase 2 | 0.044 | |
BIRC3 | baculoviral IAP repeat containing 3 | 0.043 | |
TFF1 | trefoil factor 1 | 0.043 | |
PECAM1 | platelet/endothelial cell adhesion molecule | 0.042 | |
HIF1A | hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 0.041 | |
CCND1 | cyclin D1 | 0.040 | |
VAV1 | vav 1 guanine nucleotide exchange factor | 0.039 | |
PTK2B | PTK2B protein tyrosine kinase 2 beta | 0.038 | |
INSR | insulin receptor | 0.038 | |
LCK | lymphocyte-specific protein tyrosine kinase | 0.037 | |
CXCR4 | chemokine (C-X-C motif) receptor 4 | 0.037 | |
ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.034 | |
FCGR2B | Fc fragment of IgG, low affinity IIb, receptor (CD32) | 0.034 | |
STAT6 | signal transducer and activator of transcription 6, interleukin-4 induced | 0.033 | |
GRB7 | growth factor receptor-bound protein 7 | 0.033 | |
CD19 | CD19 molecule | 0.031 | |
MUC1 | mucin 1, cell surface associated | 0.031 | |
TCF4 | transcription factor 4 | 0.030 | |
HDAC9 | histone deacetylase 9 | 0.030 | |
CDKN1A | cyclin-dependent kinase inhibitor 1A (p21, Cip1) | 0.029 | |
GAS7 | growth arrest-specific 7 | 0.028 | |
CTNNB1 | catenin (cadherin-associated protein), beta 1, 88kDa | 0.027 | |
CDCP1 | CUB domain containing protein 1 | 0.027 | |
TP53 | tumor protein p53 | 0.027 | |
SH2D1A | SH2 domain containing 1A | 0.027 | |
ARNT | aryl hydrocarbon receptor nuclear translocator | 0.026 | |
PRKCB | protein kinase C, beta | 0.025 | |
RB1 | retinoblastoma 1 | 0.025 | |
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.025 | |
UHRF2 | ubiquitin-like with PHD and ring finger domains 2 | 0.024 | |
HLA-DQA1 | major histocompatibility complex, class II, DQ alpha 1 | 0.024 | |
PPP1CC | protein phosphatase 1, catalytic subunit, gamma isozyme | 0.024 | |
USP7 | ubiquitin specific peptidase 7 (herpes virus-associated) | 0.024 | |
PIAS4 | protein inhibitor of activated STAT, 4 | 0.023 | |
ABI2 | abl-interactor 2 | 0.023 | |
MSH5 | mutS homolog 5 (E. coli) | 0.022 | |
CCND3 | cyclin D3 | 0.022 | |
CYSLTR1 | cysteinyl leukotriene receptor 1 | 0.022 | |
LY96 | lymphocyte antigen 96 | 0.022 | |
LAIR1 | leukocyte-associated immunoglobulin-like receptor 1 | 0.021 | |
IRF4 | interferon regulatory factor 4 | 0.021 | |
IL22RA1 | interleukin 22 receptor, alpha 1 | 0.020 | |
BAK1 | BCL2-antagonist/killer 1 | 0.020 | |
WASF1 | WAS protein family, member 1 | 0.019 | |
CDKN2C | cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4) | 0.019 | |
ID2 | inhibitor of DNA binding 2, dominant negative helix-loop-helix protein | 0.019 | |
GRB10 | growth factor receptor-bound protein 10 | 0.018 | |
PILRA | paired immunoglobin-like type 2 receptor alpha | 0.018 | |
PAG1 | phosphoprotein associated with glycosphingolipid microdomains 1 | 0.018 | |
NCOA7 | nuclear receptor coactivator 7 | 0.018 | |
TNFAIP3 | tumor necrosis factor, alpha-induced protein 3 | 0.018 | |
RAPGEF1 | Rap guanine nucleotide exchange factor (GEF) 1 | 0.018 | |
HDAC4 | histone deacetylase 4 | 0.018 | |
RNF144B | ring finger protein 144B | 0.017 | |
GAB2 | GRB2-associated binding protein 2 | 0.017 | |
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.017 | |
DDX17 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 17 | 0.017 | |
IRS1 | insulin receptor substrate 1 | 0.017 | |
MAPK12 | mitogen-activated protein kinase 12 | 0.017 | |
FGR | Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog | 0.016 | |
FERMT2 | fermitin family member 2 | 0.016 |
Name | Description | Probability | Func Analog Organism |
---|---|---|---|
RT1-Db1 | RT1 class II, locus Db1 | 0.011 |